Doenças cerebrovasculares - Experiência de um servicço de Medicina Interna durante 8 anos (1986 - 1993)

Authors

  • Luz Reis Brazão Internos do Internato Complementar de Medicina Interna, Centro Hospitalar do Funchal
  • Rita Graça Vieira Internos do Internato Complementar de Medicina Interna, Centro Hospitalar do Funchal
  • José Júlio Nóbrega Internos do Internato Complementar de Medicina Interna, Centro Hospitalar do Funchal
  • Decla Freitas Assistente Hospitalar de Medicina Interna Centro Hospitalar do Funchal
  • Ana Paula Reis Assistente Hospitalar de Medicina Interna, Centro Hospitalar do Funchal
  • José Luís Andrade Assistente Hospitalar de Medicina Interna, Centro Hospitalar do Funchal
  • Chaves Teixeira Assistente Hospitalar de Medicina Interna, Centro Hospitalar do Funchal
  • João Tranquada Chefe de Serviço de Medicina I, Centro Hospitalar do Funchal
  • Jorge Nóbrega Araújo Director do Serviço de Medicina 1, Centro Hospitalar do Funchal

Keywords:

.

Abstract

Objective: To evaluate the experience of a de­ partment of internal medicine in relation to ce­rebrovascular disease highlightning the im­portance of risk factors associated with this disease.

Design: Retrospective review of medical re­cords from 1986 to 1993.

Setting: Department of Internal Medicine in a tertian care Hospital.

Patients: One thousand three hundred and se­ venty three (1373) patients admitted with the diagnosis ofcerebrovasculardisease in which the Jollowing parameters were evaluated:

Distribution by sex, age and season, indivi­dual risk factors (hypertension, diabetes me­llitus, hyperlipidemia and cardiovascular diseases), localization of lesion, type of cerebro­ vascular disease, morbidity and mortality.

Interventions: Since 1992 we administered ni­modipina to our patients at a dose of 240mg P.O./day with subarachnoide hemorraghea and 120mg P.O./day with cerebrovascular di­sease of ischemic etiology.

Measurements and main results: There was a greater incidence of cerebrovascular disease infemales and in the age group between 71 and 80 years. It occured more Jfemia were the most Jrequent risk Jactors representing 67,3% and 41% of the total.

The left hemisphere of the brain was the most often involved and cerebrovascular disease of ischemic etiology the most frequent, represen­ ting 78,2% of the total Mortality was 17,9%, we would like to stress that during the eight years studied the morta­ lity rate reduced with a significant decrease since 1992.

Conclusions: Cerebrovascular diseases was the most common cause of admission between 1986 and 1993.

Taking into account the importance of the riskfactor we would like to stress that the in­cidence of cerebrovascular disease maybe reduced if we ali cooperate towards a better prevention of some of the risk factors associ­ated with this disease, namely hypertension, hyperlipidemia and diabetes mellitus.

Downloads

Download data is not yet available.

References

Di-Lasci G, Salivini S, Nimodipine in ischemic cerebropathy- Clin Ter1993Feb; 142(2): 123(6)

Direcção Geral de Saúde. Risco de morrer em Portugal. Lisboa (vários anos)

AdamsJr. HP, Love BL, Radical management of aneurysmal suba­ racnoid hemorrhage. Stroke 2ª edição, 1992: 1029 - 1048

Falcão JM, Doença cerebrovascular em Portugal. Alguns dados epidemiológicos. Fev. 1992. Epidemiologia - Direcção Geral de Saúde

Grotta CJ, Pharmacologic Modification of actue cerebral ische­mic. Stroke 2ª edição, 1992: 943 - 948

Coronna JJ, Cerebrovascular .Diseases. Kelley Textbook of Inter­nal Medicine 2ª Edição - 1992 - Cap. 458: Pág. 2161 - 2168

Ferro JM, Canhão P, Melo TP, Campos JG, Trindade A, Antunes JL, Nimodipina na hemorragia subaracnoideia. Separata da acta médica Portuguesa 1991, 4: 138-140

Kistler J Philip, Ropper Allan A, Martin Joseph B, Cerebrovascu­lar diseases. Harrison's Principles of Internal Medicine, 1991, 351: 1977 - 2002

Mohr JP, Meta - Analysis of oral nimodipine trials in acure ische­mic stroke, New York Neurological Institute Cerebrovascular Disease. 1993, August, 9, 264:1-14.

Lees KR, Therapeutic interventions in acure stroke Br J Clin - Pharmacol, 1992; Dec. 34 (6); 486 (93)

Nadir J; Bogousslavsky J, Treatment of acure cerebral infarction Curr. Opin. Neurol. Neurosurg., 1993; Feb. 6 (1 ); 51 - 4

OMS - World Health Statistics Annual Genéve (vários anos)

Wolf Philip A, Cobb Janet L, D'Agostino Ralph B, Epidemiology of stroke. Stroke 2ª edição, 1992: 3 - 25

Stephen E Nadeau, MD. Stroke, Geriatric Medicine Medical Cli­nics of North America 1989; 73(6):1351-1369

The American Nimodipine Study group. [Published erratum appe­ ars in stroke 1992 Apr. 23 (4): 615] Clinical trial of nimodipine

in acure ischemic stroke 1992 Jan; 23 (1) 3-8

Additional Files

Published

1994-06-30

How to Cite

1.
Reis Brazão L, Graça Vieira R, Nóbrega JJ, Freitas D, Reis AP, Andrade JL, Teixeira C, Tranquada J, Nóbrega Araújo J. Doenças cerebrovasculares - Experiência de um servicço de Medicina Interna durante 8 anos (1986 - 1993). RPMI [Internet]. 1994 Jun. 30 [cited 2024 Nov. 21];1(2):90-8. Available from: https://revista.spmi.pt/index.php/rpmi/article/view/2447

Issue

Section

Original Articles

Similar Articles

You may also start an advanced similarity search for this article.

Most read articles by the same author(s)